Whitehawk Therapeutics (WHWK) Enterprise Value (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Enterprise Value of -$211.3 million for Q1 2026, up 8.57% year-over-year from -$194.6 million in Q1 2025, and down 44.99% quarter-over-quarter from -$145.7 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Enterprise Value (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Enterprise Value for 17 consecutive years, with -$211.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 8.57% year-over-year to -$211.3 million; the TTM figure through Mar 2026 stood at -$211.3 million (up 8.57% YoY), while the FY2025 annual figure was -$145.7 million, down 208.44% from the prior year.
- Enterprise Value fell to -$211.3 million in Q1 2026 per WHWK's latest filing, from -$145.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$47.2 million in Q4 2024 and bottomed at -$231.1 million in Q1 2025.
- Historically, Enterprise Value has averaged -$136.6 million across 5 years, with a median of -$134.9 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 232.87% — and 2024, when it jumped 56.6%.
- Whitehawk Therapeutics' Enterprise Value stood at -$172.6 million in 2022, then surged by 36.92% to -$108.8 million in 2023, then surged by 56.6% to -$47.2 million in 2024, then tumbled by 208.44% to -$145.7 million in 2025, then sank by 44.99% to -$211.3 million in 2026.
- Business Quant data shows WHWK's Enterprise Value at -$211.3 million in Q1 2026, -$145.7 million in Q4 2025, and -$162.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | -294.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -294.75 Mn |
| Mar 31, 2026 | -211.25 Mn |
| Dec 31, 2025 | -145.70 Mn |
| Sep 30, 2025 | -162.60 Mn |
| Jun 30, 2025 | -177.20 Mn |
| Mar 31, 2025 | -231.06 Mn |
| Dec 31, 2024 | -47.24 Mn |
| Sep 30, 2024 | -62.62 Mn |
| Jun 30, 2024 | -78.57 Mn |
| Mar 31, 2024 | -88.27 Mn |
| Dec 31, 2023 | -108.85 Mn |
| Sep 30, 2023 | -119.34 Mn |
| Jun 30, 2023 | -134.89 Mn |
| Mar 31, 2023 | -151.17 Mn |
| Dec 31, 2022 | -172.56 Mn |
| Sep 30, 2022 | -183.01 Mn |
| Jun 30, 2022 | -118.74 Mn |
| Mar 31, 2022 | -129.85 Mn |
| Dec 31, 2021 | -148.99 Mn |
| Sep 30, 2021 | -161.38 Mn |